维普中文期刊产品整合服务
52篇 您的检索式:作者名="FAULL R"
    题名 作者 年代 出处 被引量
1The use of c-fos as a metabolic marker in neuronal pathway tracing 显示文摘Dragunow M Faull R 1989Neurosci Methods1989,29,3:1
2Endogenous plasmacarnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients显示文摘Reuter SE Faull R J Ranieri E 2009Nephrol Dial Transplant2009,24,3:1
3Phamacokinetics of L-camitine in patients with end-stage renal disease undergoing longterm hemodialyses 显示文摘Evans AM Faull R Fomasini G 2000Clin Pharmacol Ther2000,68,8:1
4Nocardiosis presenting as a lung mass in a kidney transplant recipient显示文摘Hakim H Rao N N Faull R J 2015Nephrolo- gy (Carlton)2015,20,1:1
5Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis显示文摘EVANS A M FAULL R FORNASINI G 2000Clin Pharmacol Ther2000,68,3:1
6The effects of the N-terminal tripeptide of insulin-like growth factor-1, Glycine-Proline-Glutamate in different regions following hypoxic-ischemic brain injury in adult rats 显示文摘Guan J Woldvogel H Faull R 1999Neuroscience1999,89,3:1
7Differential sensitivity of calbindin and parvalbumin immunoreactive cells in the striatum to excitotoxins显示文摘Waldvogel H J Faull R L Williams M N 1991Brain Res1991,546,2:1
8Phamacokinetics of Lcarnitine in patients with endstage renal disease undergoing longterm hemodialysis 显示文摘EvansAM Faull R Fornasini G 2000Clin PharmacolTher2000,68,8:1
9Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long term hemodialysis显示文摘Evans AM Faull R Fornasini G 2000Clin Pharmacol Ther2000,68,:1
10Pharmacokinetics of L -carnitine in patients with end-stage renal disease undergoing long-term hemodialysis显示文摘Evans AM Faull R Fornasini G 2000Clin Pharmacol Ther2000,68,3:1
11Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long term hemodial- ysis显示文摘Evans AM Faull R Fornasini G 2000Clin Pharmacol Ther2000,68,3:1
12Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex,visual cortex and hippocampus of control and Alzheimer's disease brains显示文摘NORRIS P J FAULL R L EMSON P C 1996Brain Res Mol Brain Res1996,41,12:1
13Phamacokinetics of Lcarnitine in patients with endstage renal disease undergoing longterm hemodialysis 显示文摘EvansAM Faull R Fornasini G 2000Clin Pharmacol Ther2000,68,3:1
14The use of c-fos as a metabolic marker in neuronal pathway tracing显示文摘Draguow M Faull R 1989Neutosci Meth1989,29,:1
15Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing longterm hemodialysis显示文摘Evans AM Faull R Fornasini G 2000Clin Pharmacol Ther2000,68,3:1
16Epidermal growth factormodt-fies the expression and function of extracellular matrix adhesionreceptors expressed by peritoneal mesothelial cells from patientson CAPD显示文摘Leavesley D I Stanley J M’Faull R J 1999Nephrol Dial Transplant1999,14,:1
17Pharmacokinetics of Lcarnitine in patients with end-stage renal disease undergoing longterm hemodialysis显示文摘Evans AM Faull R Fornasini G 2000Clin Pharmacol Ther2000,68,:1
18The effect soft the Nter-minal tripe ptide of insulin like growth factor-1, glycine-proline-glutamate in different regions following hypoxie ischemic brain injury in adult rats显示文摘Guan J Waldvogel H J Faull R L 1999Neuro Sci1999,89,3:1
19The use of c-fos as a metablic marker in nueuronal pathway tracing显示文摘Dragunow M Faull R 1989J Neurosci Methods1989,29,1:1
20The use of c-fos as a metabolic marker in neuronal pathway tracing 显示文摘Dragunow M Faull R 1989J Neuroaci Methods1989,,29:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费